Wei Li1, Subroto Ghose, Kelly Gleason, Anita Begovic, Jessica Perez, John Bartko, Scott Russo, Anthony D Wagner, Lynn Selemon, Carol A Tamminga. 1. From the Division of Translational Neuroscience in Schizophrenia, Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas; the Department of Neurobiology, Yale University School of Medicine, New Haven, Conn.; the Department of Psychology and Neuroscience Program, Stanford University, Palo Alto, Calif.; and the Department of Neuroscience, Mount Sinai Medical School, New York.
Abstract
OBJECTIVE: In schizophrenia, hippocampal perfusion is increased and declarative memory function is degraded. Based on an a priori model of hippocampal dysfunction in schizophrenic psychosis, the authors postulated molecular and cellular changes in CA3 consistent with increased NMDA receptor signaling. METHOD: Postmortem hippocampal subfield tissue (CA3, CA1) from subjects with schizophrenia and nonpsychiatric comparison subjects was analyzed using Western blotting and Golgi histochemistry to examine the hypothesized outcomes. RESULTS: The GluN2B-containing NMDA receptors (GluN2B/GluN1) and their associated postsynaptic membrane protein PSD95 were both increased in schizophrenia in CA3 tissue, but not in CA1 tissue. Quantitative analyses of Golgi-stained hippocampal neurons showed an increase in spine density on CA3 pyramidal cell apical dendrites (stratum radiatum) and an increase in the number of thorny excrescences. CONCLUSIONS: The hippocampal data are consistent with increased excitatory signaling in CA3 and/or with an elevation in silent synapses in CA3, a state that may contribute to an increase in long-term potentiation in CA3 with subsequent stimulation and "unsilencing." These changes are plausibly associated with increased associational activity in CA3, with degraded declarative memory function, and with formation of false memories with psychotic content. The influence of these hyperactive hippocampal projections on targets in the limbic neocortex could contribute to components of schizophrenia manifestations in other cerebral regions.
OBJECTIVE: In schizophrenia, hippocampal perfusion is increased and declarative memory function is degraded. Based on an a priori model of hippocampal dysfunction in schizophrenic psychosis, the authors postulated molecular and cellular changes in CA3 consistent with increased NMDA receptor signaling. METHOD: Postmortem hippocampal subfield tissue (CA3, CA1) from subjects with schizophrenia and nonpsychiatric comparison subjects was analyzed using Western blotting and Golgi histochemistry to examine the hypothesized outcomes. RESULTS: The GluN2B-containing NMDA receptors (GluN2B/GluN1) and their associated postsynaptic membrane protein PSD95 were both increased in schizophrenia in CA3 tissue, but not in CA1 tissue. Quantitative analyses of Golgi-stained hippocampal neurons showed an increase in spine density on CA3 pyramidal cell apical dendrites (stratum radiatum) and an increase in the number of thorny excrescences. CONCLUSIONS: The hippocampal data are consistent with increased excitatory signaling in CA3 and/or with an elevation in silent synapses in CA3, a state that may contribute to an increase in long-term potentiation in CA3 with subsequent stimulation and "unsilencing." These changes are plausibly associated with increased associational activity in CA3, with degraded declarative memory function, and with formation of false memories with psychotic content. The influence of these hyperactive hippocampal projections on targets in the limbic neocortex could contribute to components of schizophrenia manifestations in other cerebral regions.
Authors: Robert E McCullumsmith; Lars V Kristiansen; Monica Beneyto; Elizabeth Scarr; Brian Dean; James H Meador-Woodruff Journal: Brain Res Date: 2006-11-17 Impact factor: 3.252
Authors: Carol A Tamminga; Sarah Southcott; Carolyn Sacco; Anthony D Wagner; Subroto Ghose Journal: Schizophr Bull Date: 2012-04-24 Impact factor: 9.306
Authors: Francine M Benes; Benjamin Lim; David Matzilevich; Sivan Subburaju; John P Walsh Journal: Proc Natl Acad Sci U S A Date: 2008-12-22 Impact factor: 11.205
Authors: Magdalene I Schlesiger; John C Cressey; Brittney Boublil; Julie Koenig; Neal R Melvin; Jill K Leutgeb; Stefan Leutgeb Journal: Neurobiol Learn Mem Date: 2013-06-04 Impact factor: 2.877
Authors: Matthew E Hudgens-Haney; Lauren E Ethridge; Jennifer E McDowell; Sarah K Keedy; Godfrey D Pearlson; Carol A Tamminga; Matcheri S Keshavan; John A Sweeney; Brett A Clementz Journal: Schizophr Res Date: 2017-08-24 Impact factor: 4.939
Authors: Anindita Sarkar; Arianna Mei; Apua C M Paquola; Shani Stern; Cedric Bardy; Jason R Klug; Stacy Kim; Neda Neshat; Hyung Joon Kim; Manching Ku; Maxim N Shokhirev; David H Adamowicz; Maria C Marchetto; Roberto Jappelli; Jennifer A Erwin; Krishnan Padmanabhan; Matthew Shtrahman; Xin Jin; Fred H Gage Journal: Cell Stem Cell Date: 2018-05-03 Impact factor: 24.633